[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

RU92016400A - Применение дифенилбутил-пиперазинкарбоксамидов при лечении токсикоманий - Google Patents

Применение дифенилбутил-пиперазинкарбоксамидов при лечении токсикоманий

Info

Publication number
RU92016400A
RU92016400A RU92016400/14A RU92016400A RU92016400A RU 92016400 A RU92016400 A RU 92016400A RU 92016400/14 A RU92016400/14 A RU 92016400/14A RU 92016400 A RU92016400 A RU 92016400A RU 92016400 A RU92016400 A RU 92016400A
Authority
RU
Russia
Prior art keywords
treatment
diphenylbutyl
piperazincarboxamides
application
toxic
Prior art date
Application number
RU92016400/14A
Other languages
English (en)
Other versions
RU2095062C1 (ru
Inventor
Бьерк Андерс
Кристенссон Эрик
Original Assignee
Каби Фармациа АБ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9100860A external-priority patent/SE9100860D0/xx
Application filed by Каби Фармациа АБ filed Critical Каби Фармациа АБ
Publication of RU92016400A publication Critical patent/RU92016400A/ru
Application granted granted Critical
Publication of RU2095062C1 publication Critical patent/RU2095062C1/ru

Links

Claims (1)

  1. Изобретение относится к применению некоторых дифенилбутил-пиперазинкарбоксамидов, в частности амперизида, 4- 4,4-бис(4-фторфенил) бутил-этил-1-пиперазинкарбоксамида и их солей при лечении нарушений, связанных с пристрастием к различным токсичным веществам. Кроме того лечение способствует облегчению симптомов отмены и изменения поведенческой реакции стремления к наркотическому веществу.
RU9292016400A 1991-03-22 1992-03-23 Блокатор синдрома отмены, являющегося результатом привыкания к чрезмерному потреблению лекарств или веществ, вызывающих привыкание, фармакологическая композиция на его основе и способ облегчения или предотвращения синдрома отмены RU2095062C1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9100860A SE9100860D0 (sv) 1991-03-22 1991-03-22 New use
SE9100860-7 1991-03-22
PCT/SE1992/000182 WO1992016211A1 (en) 1991-03-22 1992-03-23 New use of diphenylbutyl-piperazinecarboxamides in the treatment of substance disorders

Publications (2)

Publication Number Publication Date
RU92016400A true RU92016400A (ru) 1995-02-10
RU2095062C1 RU2095062C1 (ru) 1997-11-10

Family

ID=20382242

Family Applications (1)

Application Number Title Priority Date Filing Date
RU9292016400A RU2095062C1 (ru) 1991-03-22 1992-03-23 Блокатор синдрома отмены, являющегося результатом привыкания к чрезмерному потреблению лекарств или веществ, вызывающих привыкание, фармакологическая композиция на его основе и способ облегчения или предотвращения синдрома отмены

Country Status (24)

Country Link
US (2) US5434156A (ru)
EP (1) EP0538422B1 (ru)
JP (1) JP3221611B2 (ru)
KR (1) KR100196674B1 (ru)
AT (1) ATE199057T1 (ru)
AU (1) AU653797B2 (ru)
BG (1) BG61829B1 (ru)
BR (1) BR9204969A (ru)
CA (1) CA2083505C (ru)
CZ (1) CZ282222B6 (ru)
DE (1) DE69231680T2 (ru)
DK (1) DK0538422T3 (ru)
EE (1) EE02973B1 (ru)
ES (1) ES2154261T3 (ru)
GR (1) GR3035805T3 (ru)
HU (2) HU9203632D0 (ru)
IE (1) IE920920A1 (ru)
NO (1) NO301311B1 (ru)
PT (1) PT100279B (ru)
RO (1) RO109702B1 (ru)
RU (1) RU2095062C1 (ru)
SE (1) SE9100860D0 (ru)
SK (1) SK279237B6 (ru)
WO (1) WO1992016211A1 (ru)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100860D0 (sv) * 1991-03-22 1991-03-22 Kabi Pharmacia Ab New use
SE9201239D0 (sv) * 1992-04-21 1992-04-21 Kabi Pharmacia Ab Agents for treating substance abuse disorders
JP3571114B2 (ja) * 1995-07-11 2004-09-29 ポーラ化成工業株式会社 麻薬拮抗剤
US6265393B1 (en) 1998-08-07 2001-07-24 Heinrichs William Leroy Prevention of endometriosis signs or symptons
US6090780A (en) * 1999-04-07 2000-07-18 Chandon Prasad Histidyl-proline diketopiperazine and method of use
GB9923748D0 (en) 1999-10-07 1999-12-08 Glaxo Group Ltd Chemical compounds
USRE39921E1 (en) 1999-10-07 2007-11-13 Smithkline Beecham Corporation Chemical compounds
GB0025354D0 (en) 2000-10-17 2000-11-29 Glaxo Group Ltd Chemical compounds
US20050192271A1 (en) * 2003-07-15 2005-09-01 Hythiam, Inc. Use of selective chloride channel modulators to treat alcohol and/or stimulant substance abuse
CA2433833C (en) * 2001-01-17 2009-06-02 Juan Jose Legarda Ibanez Use of flumazenil in developing a drug for the treatment of alcohol dependence
US7183410B2 (en) * 2001-08-02 2007-02-27 Bidachem S.P.A. Stable polymorph of flibanserin
US20030060475A1 (en) * 2001-08-10 2003-03-27 Boehringer Ingelheim Pharma Kg Method of using flibanserin for neuroprotection
UA78974C2 (en) * 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
GB0203020D0 (en) 2002-02-08 2002-03-27 Glaxo Group Ltd Chemical compounds
US7482365B2 (en) 2002-02-08 2009-01-27 Glaxo Group Limited Piperidylcarboxamide derivatives and their use in the treatment of tachykinin-mediated diseases
GB0203022D0 (en) 2002-02-08 2002-03-27 Glaxo Group Ltd Chemical compounds
US20050239798A1 (en) * 2004-04-22 2005-10-27 Boehringer Ingelheim Pharmaceuticals, Inc. Method for the treatment of premenstrual and other female sexual disorders
RU2445095C2 (ru) * 2004-04-22 2012-03-20 Бёрингер Ингельхайм Интернациональ Гмбх Новые фармацевтические композиции для лечения сексуальных расстройств
US20060025420A1 (en) * 2004-07-30 2006-02-02 Boehringer Ingelheimn International GmbH Pharmaceutical compositions for the treatment of female sexual disorders
EP1789048A1 (en) * 2004-09-03 2007-05-30 Boehringer Ingelheim International GmbH Method for the treatment of attention deficit hyperactivity disorder
EP1858516A1 (en) * 2005-03-04 2007-11-28 Boehringer Ingelheim International GmbH Pharmaceutical compositions for the treatment and/or prevention of depression
WO2006096439A2 (en) * 2005-03-04 2006-09-14 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
US20060199805A1 (en) * 2005-03-04 2006-09-07 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
EP1904182A2 (en) * 2005-05-06 2008-04-02 Boehringer Ingelheim International GmbH Method for the treatment of drug abuse with flibanserin
JP2008540673A (ja) * 2005-05-19 2008-11-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 薬剤誘発性性機能不全の治療方法
WO2006125041A1 (en) * 2005-05-19 2006-11-23 Boehringer Ingelheim International Gmbh Method for the treatment of sexual dysfunctions due to medical conditions
WO2007014929A1 (en) 2005-08-03 2007-02-08 Boehringer Ingelheim International Gmbh Use of flibanserin in the treatment of obesity
US20070123540A1 (en) * 2005-10-29 2007-05-31 Angelo Ceci Sexual desire enhancing medicaments comprising benzimidazolone derivatives
EP1945214A1 (en) * 2005-10-29 2008-07-23 Boehringer Ingelheim International GmbH Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
US20070105869A1 (en) * 2005-11-08 2007-05-10 Stephane Pollentier Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
AU2007247094B2 (en) * 2006-05-09 2012-11-01 Sprout Pharmaceuticals, Inc. Use of flibanserin for the treatment of post-menopausal Sexual Desire Disorders
WO2008000760A1 (en) * 2006-06-30 2008-01-03 Boehringer Ingelheim International Gmbh Flibanserin for the treatment of urinary incontinence and related diseases
CA2657043A1 (en) * 2006-07-14 2008-01-17 Boehringer Ingelheim International Gmbh Use of flibanserin for the treatment of sexual disorders in females
CL2007002214A1 (es) * 2006-08-14 2008-03-07 Boehringer Ingelheim Int Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
CA2660476C (en) 2006-08-14 2015-11-17 Boehringer Ingelheim International Gmbh Formulations of flibanserin and method for manufacturing the same
BRPI0716436B8 (pt) * 2006-08-25 2021-05-25 Boehringer Ingelheim Int sistema de liberação controlada e método para fabricação do mesmo
CL2008002693A1 (es) * 2007-09-12 2009-10-16 Boehringer Ingelheim Int Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO154582C (no) * 1978-10-20 1986-11-05 Ferrosan Ab Analogifremgangsmaate for fremstilling av terapeutisk aktive difenyl-dibutylpiperazinkarboksamider.
SE9100860D0 (sv) * 1991-03-22 1991-03-22 Kabi Pharmacia Ab New use

Similar Documents

Publication Publication Date Title
RU92016400A (ru) Применение дифенилбутил-пиперазинкарбоксамидов при лечении токсикоманий
RU93058261A (ru) Гетероциклические амины, используемые в терапии астмы и воспаления респираторного тракта
IT1246983B (it) L-2'-desossiuridine e composizioni farmaceutiche che le contengono.
KR930702000A (ko) 노년기 치매, 식용항진, 편두통, 또는 식용불량의 치료를 위한 파로세틴의 사용
RU92016463A (ru) Применение производных цистина для изготовления лекарственных препаратов с иммуномоделирующим действием, фармацевтические композиции на их основе
DE3889062D1 (de) Monoklonaler Antikörper gegen humanen BCDF.
DE69106630D1 (de) Wässerige kosmetische Zusammensetzung und dessen Herstellungsverfahren.
RU94002133A (ru) 6-хлор-5-фтор-3-(2-теноил)-2-оксиндол-1-карбоксамид как аналгезирующее и противовоспалительное средство
FR2681325B1 (fr) Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique.
CA2176298A1 (en) A single high dose fluoroquinolone treatment
DK0562705T3 (da) Anvendelse af L-deprenyl til fremstilling af et lægemiddel til behandling af Cushings sygdom
IT1229872B (it) Dispositivo per l'evaporazione di metalli.
FR2703995B1 (fr) 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.
FR2675802B1 (fr) Antiserotonines, leur preparation et les medicaments les contenant.
TR199800801T2 (xx) Travmatik beyin yaralanmalar�n�n tedavisi.
NO911430L (no) Stoffbehandlingsmetode.
DE69331008D1 (de) Verwendung von cotinin zur linderung des tabakentzugssyndrom
ATE28566T1 (de) Zellgiftiges arzneimittel enthaltend mindestens ein immunotoxin und ein amin.
KR910004188A (ko) 세트랄린을 사용한 화학약품 의존성의 치료방법
KR960003718A (ko) 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용
FR2677223B1 (fr) Composition insecticide a base de rotenone, notamment pour le traitement des parasites humains et animaux.
FR2673944B1 (fr) Derives de l'1,8-naphtalimide, leur procede de preparation et les compositions pharmaceutiques les contenant.
RU93016671A (ru) Иммуномодулятор
RU93003456A (ru) Лекарственный препарат
RU97106644A (ru) Способ лечения туберкулезного увеита глаза